Home / Companies / Praxis Precision Medicines, Inc. / 26 Jun 2025
Praxis Precision Medicines, Inc.: meeting of 26 Jun 2025
Votes reported on Form N-PX, item by item
258 Form N-PX filers reported votes at the Praxis Precision Medicines, Inc. meeting of 26 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 81.3% of reported votes for; 36 filers withheld from or voted against at least one nominee.
286 vote records from 86 filers. 4 of the 86 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
345 vote records from 258 filers. 189 of the 251 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
142 vote records from 85 filers. 1 of the 85 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | Against * | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | Split or no vote | Against * | For |
| Franklin Templeton | Split or no vote | Against * | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | For | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | Split or no vote | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | No report | Against * | No report |
| Goldman Sachs | Split or no vote | Against * | For |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | Split or no vote | Against * | For |
| SEI | Split or no vote | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | Split or no vote | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | Split or no vote | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | Against * | No report |
| Pacific Life funds | For | Against * | For |
| Global X | Split or no vote | Against * | For |
| Transamerica | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Split or no vote | Against * | For |
| MassMutual | For | Against * | For |
| Janus Henderson | For | For | For |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Praxis Precision Medicines, Inc. meeting?
258 Form N-PX filers reported votes at the meeting of 26 Jun 2025. On say-on-pay, 189 of 251 voted against management (75.3%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Praxis Precision Medicines, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Praxis Precision Medicines, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Praxis Precision Medicines, Inc. with a meeting date within three days of 26 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.